CLI Ventures

What is CLI Ventures?

CLI Ventures is a venture capital fund based in Palo Alto, California, that specializes in equity investments.

With a focus on early to late stage companies, they align their investments with firms operating in a diverse array of industry sectors including healthcare, biotechnology, software, information technology and TMT, business solutions, financial services and fintech, hardware and manufacturing, IoT and wearables, clean technology, health tech and fitness, logistics and distribution, medical devices and hospital services, healthcare and wellness, investment management, life sciences, and more.

Their financial commitment is reflected in their extensive portfolio, which includes a wide range of companies.

One notable portfolio company is Compass, a technology-driven real estate platform aimed at streamlining the buying, selling, and renting process. Another is CRISPR Therapeutics, a biopharmaceutical company leveraging CRISPR/Cas9 gene-editing technology.

Additionally, they have invested in Guardant Health, which specializes in genomic cancer testing from blood samples, thereby offering a non-invasive alternative to traditional tissue biopsies. CLI Ventures' track record includes multiple IPO and M&A exits, underscoring their commitment to not only invest in but also support the growth and success of transformative companies.

Their specialization in seed, startup, and early-stage investments underscores their commitment to fostering innovation from the ground up. CLI Ventures manages over $1 billion in assets, signifying their robust financial capability to support their portfolio companies through various stages of growth.